GL1X · GenesisL1 explorer

Research workbench

Human glucokinase in complex with a synthetic activator

Analyse Human glucokinase in complex with a synthetic activator in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GOI
Type
protein
Length
448 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glucokinase
EC
2.7.1.2
UniProt
A4D2J2
Ligands
LOI, GLC
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlucokinase (EC 2.7.1.2)protein44842% helix, 21% strandA4D2J2

Ligands and binding sites

  • LOI · 2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13050.660.8134LOI
22150.540.7827empty
3720.310.7419empty

Compared structures

  • 3GOI · Human glucokinase in complex with a synthetic activator · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.